Hostname: page-component-75d7c8f48-hfkw9 Total loading time: 0 Render date: 2026-03-22T20:55:14.847Z Has data issue: false hasContentIssue false
  • English
  • Français

Overview of late-onset psychoses

Published online by Cambridge University Press:  03 March 2023

D.P. Devanand Open the ORCID record for D.P. Devanand [Opens in a new window] ,
Dilip V. Jeste ,
T. Scott Stroup  and
Terry E. Goldberg Open the ORCID record for Terry E. Goldberg [Opens in a new window]
D.P. Devanand*
Affiliation:
Department of Psychiatry, New York State Psychiatric Institute and Columbia University Irving Medical Center, New York, USA
Dilip V. Jeste
Affiliation:
Departments of Psychiatry, Neurosciences University of California San Diego, La Jolla, USA
T. Scott Stroup
Affiliation:
Department of Psychiatry, New York State Psychiatric Institute and Columbia University Irving Medical Center, New York, USA
Terry E. Goldberg
Affiliation:
Department of Psychiatry, New York State Psychiatric Institute and Columbia University Irving Medical Center, New York, USA
*
Correspondence should be addressed to: D.P. Devanand, MD, 1051 Riverside Drive, Unit 126, New York, NY, USA. Email: dpd3@cumc.columbia.edu
Get access

Abstract

Background:

Several etiologies can underlie the development of late-onset psychosis, defined by first psychotic episode after age 40 years. Late-onset psychosis is distressing to patients and caregivers, often difficult to diagnose and treat effectively, and associated with increased morbidity and mortality.

Methods:

The literature was reviewed with searches in Pubmed, MEDLINE, and the Cochrane library. Search terms included “psychosis,” “delusions,” hallucinations,” “late onset,” “secondary psychoses,” “schizophrenia,” bipolar disorder,” “psychotic depression,” “delirium,” “dementia,” “Alzheimer’s,” “Lewy body,” “Parkinson’s, “vascular dementia,” and “frontotemporal dementia.” This overview covers the epidemiology, clinical features, neurobiology, and therapeutics of late-onset psychoses.

Results:

Late-onset schizophrenia, delusional disorder, and psychotic depression have unique clinical characteristics. The presentation of late-onset psychosis requires investigation for underlying etiologies of “secondary” psychosis, which include neurodegenerative, metabolic, infectious, inflammatory, nutritional, endocrine, and medication toxicity. In delirium, psychosis is common but controlled evidence is lacking to support psychotropic medication use. Delusions and hallucinations are common in Alzheimer’s disease, and hallucinations are common in Parkinson’s disease and Lewy body dementia. Psychosis in dementia is associated with increased agitation and a poor prognosis. Although commonly used, no medications are currently approved for treating psychosis in dementia patients in the USA and nonpharmacological interventions need consideration.

Conclusion:

The plethora of possible causes of late-onset psychosis requires accurate diagnosis, estimation of prognosis, and cautious clinical management because older adults have greater susceptibility to the adverse effects of psychotropic medications, particularly antipsychotics. Research is warranted on developing and testing efficacious and safe treatments for late-onset psychotic disorders.

Keywords

older adultsecondary psychosisschizophreniadelusional disorderdementiadelirium

Information

Type
Review Article
Information
International Psychogeriatrics , Volume 36 , Special Issue 1: Issue Theme: Schizophrenia and Other Psychotic Disorders in Later Life , January 2024 , pp. 28 - 42
Copyright
© International Psychogeriatric Association 2023

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Article purchase

Temporarily unavailable

References

American Psychiatric Association (2013, 5th edition, Washington, D.C: American Psychiatric Association.Google Scholar
Badcock, J. C., Dehon, H. and Larøi, F. (2017). Hallucinations in healthy older adults: an overview of the literature and perspectives for future research. Frontiers in Psychology, 8, 1134. https://doi.org/10.3389/fpsyg.2017.01134.Google Scholar
Bolton, S., Warner, J., Harriss, E., Geddes, J. and Saunders, K. (2021). Bipolar disorder: trimodal age-at-onset distribution. Bipolar Disorders, 23, 341–356. https://doi.org/10.1111/bdi.13016.Google Scholar
Casanova, M. F., Stevens, J. R., Brown, R., Royston, C. and Bruton, C. (2002). Disentangling the pathology of schizophrenia and paraphrenia. Acta Neuropathology, 103, 313–320.Google Scholar
Chen, L. et al. (2013). White matter microstructural abnormalities in patients with late-onset schizophrenia identified by a voxel-based diffusion tensor imaging. Psychiatry Research, 212, 201–207. https://doi.org/10.1016/j.pscychresns.2012.05.009.Google Scholar
Cohen, C. I. and Reinhardt, M. M. (2020). Recovery and recovering in older adults with schizophrenia: a 5-tier model. The American Journal of Geriatric Psychiatry, Official Journal of the American Association for Geriatric Psychiatry, 28, 872–875. https://doi.org/10.1016/j.jagp.2020.03.008.Google Scholar
Creese, B., Ballard, C., Aarsland, D., Londos, E., Sharp, S. and Jones, E. (2014). Determining the association of the 5HTTLPR polymorphism with delusions and hallucinations in Lewy body dementias. The American Journal of Geriatric Psychiatry: Official Journal of the American Association for Geriatric Psychiatry, 22, 580–586. https://doi.org/10.1016/j.jagp.2012.11.001.Google Scholar
Culo, S. et al. (2010). Treating neuropsychiatric symptoms in dementia with Lewy bodies: a randomized controlled-trial. Alzheimer Disease and Associated Disorders, 24, 360–364. https://doi.org/10.1097/WAD.0b013e3181e6a4d7.Google Scholar
Cummings, J. L., Street, J., Masterman, D. and Clark, W. S. (2002). Efficacy of olanzapine in the treatment of psychosis in dementia with Lewy bodies. Dementia and Geriatric Cognitive Disorders, 13, 67–73. https://doi.org/10.1159/000048636.CrossRefGoogle ScholarPubMed
Devanand, D. P. et al. (1997). The course of psychopathologic features in mild to moderate Alzheimer disease. Archives of General Psychiatry, 54, 257–263. https://doi.org/10.1001/archpsyc.1997.01830150083012.Google Scholar
Devanand, D. P. et al. (2012). Relapse risk after discontinuation of risperidone in Alzheimer’s disease. The New England Journal of Medicine, 367, 1497–1507. https://doi.org/10.1056/NEJMoa1114058.Google Scholar
Devanand, D. P. and Krueger, R. B. (1994). Electroconvulsive therapy in the elderly. Current Opinion in Psychiatry, 7, 364–369.Google Scholar
Devanand, D. P., Lee, S., Huey, E. D. and Goldberg, T. E. (2022). Associations between neuropsychiatric symptoms and neuropathological diagnoses of Alzheimer disease and related dementias. JAMA Psychiatry, 79, 359–367. https://doi.org/10.1001/jamapsychiatry.2021.4363.Google Scholar
Dols, A. and Beekman, A. (2018). Older Age Bipolar Disorder. Psychiatric Clinics of North America, 41, 95–110.Google Scholar
Evans, D. L., Byerly, M. J. and Greer, R. A. (1995). Secondary mania: diagnosis and treatment. The Journal of Clinical Psychiatry, 56, 31–37.Google Scholar
Farber, N. B. et al. (2000). Increased neocortical neurofibrillary tangle density in subjects with Alzheimer disease and psychosis. Archives of General Psychiatry, 57, 1165–1173. https://doi.org/10.1001/archpsyc.57.12.1165.Google Scholar
Ffytche, D. H. et al. (2017). The psychosis spectrum in Parkinson disease. Nature Reviews Neurology, 13, 81–95. https://doi.org/10.1038/nrneurol.2016.200.Google Scholar
Fischer, C. E. et al. (2020). Revisiting criteria for psychosis in Alzheimer’s Disease and related dementias: toward better phenotypic classification and biomarker research. Journal of Alzheimer’s Disease: JAD, 73, 1143–1156. https://doi.org/10.3233/JAD-190828.Google Scholar
Gerhard, T. et al. (2014). Comparative mortality risks of antipsychotic medications in community-dwelling older adults. The British Journal of Psychiatry, 205, 44–51. https://doi.org/10.1192/bjp.bp.112.122499.CrossRefGoogle ScholarPubMed
Goldberg, T. E. et al. (2020). Association of delirium with long-term cognitive decline: a meta-analysis. JAMA Neurology, 77, 1373–1381. https://doi.org/10.1001/jamaneurol.2020.2273.Google Scholar
González-Rodrígues, A. et al. (2022). Delusional disorder in old age: a hypothesis-driven review of recent work focusing on epidemiology, clinical aspects, and outcomes. International Journal of Environmental Research and Public Health, 19, 7911. https://doi.org/10.3390/ijerph19137911.Google Scholar
González-Rodríguez, A. and Seeman, M. V. (2019). The association between hormones and antipsychotic use: a focus on postpartum and menopausal women. Therapeutic Advances in Psychopharmacology, 9, 2045125319859973. https://doi.org/10.1177/2045125319859973.Google Scholar
Gournellis, R. et al. (2018). Psychotic (delusional) depression and completed suicide: a systematic review and meta-analysis. Annals of General Psychiatry, 17, 39. https://doi.org/10.1186/s12991-018-0207-1.CrossRefGoogle ScholarPubMed
Graff-Guerrero, A. et al. (2015). Evaluation of antipsychotic dose reduction in late-life schizophrenia: a prospective dopamine D2/D3 receptor occupancy study. JAMA Psychiatry, 72, 927–934.Google Scholar
Granholm, E., Holden, J., Link, P. C., McQuaid, J. R. and Jeste, D. V. (2013). Randomized controlled trial of cognitive behavioral social skills training for older consumers with schizophrenia: defeatist performance attitudes and functional outcome. The American Journal of Geriatric Psychiatry: Official Journal of the American Association for Geriatric Psychiatry, 21, 251–262. https://doi.org/10.1016/j.jagp.2012.10.014.Google Scholar
Harrison, J. E., Weber, S., Jakob, R. and Chute, C. G. (2021). ICD-11: an international classification of diseases for the twenty-first century. BMC Med Informatics and Decision Making, 21(Suppl 6), 206. https://doi.org/10.1186/s12911-021-01534-6.Google Scholar
Hayhurst, C. J., Pandharipande, P. P. and Hughes, C. G. (2016). Intensive care unit delirium: a review of diagnosis, prevention, and treatment. Anesthesiology, 125, 1229–1241. https://doi.org/10.1097/ALN.0000000000001378.Google Scholar
Hollingworth, P. et al. (2012). Genome-wide association study of Alzheimer’s disease with psychotic symptoms. Molecular Psychiatry, 17, 1316–1327. https://doi.org/10.1038/mp.2011.125.Google Scholar
Howard, R, et al. (2018). Antipsychotic treatment of very late-onset schizophrenia-like psychosis (ATLAS): a randomised, controlled, double-blind trial. The Lancet Psychiatry, 5, 553–563. https://doi.org/10.1016/S2215-0366(18)30141-X.Google Scholar
Howard, R., Rabins, P. V., Seeman, M. V. and Jeste, D. V. (2000). Late-onset schizophrenia and very-late-onset schizophrenia-like psychosis: an international consensus. The International Late-Onset Schizophrenia Group. The American Journal of Psychiatry, 157, 172–178. https://doi.org/10.1176/appi.ajp.157.2.172.Google Scholar
Huybrechts, K. F. et al. (2012). Differential risk of death in older residents in nursing homes prescribed specific antipsychotic drugs: population based cohort study. BMJ, 344, e977–e977. https://doi.org/10.1136/bmj.e977.Google Scholar
Inouye, S. K., Westendorp, R. G. and Saczynski, J. S. (2014). Delirium in elderly people. The Lancet, 383, 911–922. https://doi.org/10.1016/S0140-6736(13)60688-1.Google Scholar
Jeste, D. V. and Finkel, S. I. (2000). Psychosis of Alzheimer’s disease and related dementias. Diagnostic criteria for a distinct syndrome. The American Journal of Geriatric Psychiatry: Official Journal of the American Association for Geriatric Psychiatry, 8, 29–34. https://doi.org/10.1097/00019442-200002000-00004.Google Scholar
Jeste, D. V., Wolkowitz, O. M. and Palmer, B. W. (2011). Divergent trajectories of physical, cognitive, and psychosocial aging in schizophrenia. Schizophrenia Bulletin, 37, 451–455. https://doi.org/10.1093/schbul/sbr026.Google Scholar
Jin, H. et al. (2013). Comparison of longer-term safety and effectiveness of 4 atypical antipsychotics in patients over age 40: a trial using equipoise-stratified randomization. The Journal of Clinical Psychiatry, 74, 10–18. https://doi.org/10.4088/JCP.12m08001.Google Scholar
Jonas, K., Abi-Dargham, A. and Kotov, R. (2021). Two hypotheses on the high incidence of dementia in psychotic disorders. JAMA Psychiatry, 78, 1305–1306. https://doi.org/10.1001/jamapsychiatry.2021.2584.Google Scholar
Katz, I., de Deyn, P. P., Mintzer, J., Greenspan, A., Zhu, Y. and Brodaty, H. (2007). The efficacy and safety of risperidone in the treatment of psychosis of Alzheimer’s disease and mixed dementia: a meta-analysis of 4 placebo-controlled clinical trials. International Journal of Geriatric Psychiatry, 22, 475–484. https://doi.org/10.1002/gps.1792.Google Scholar
Keshavan, M. S. and Kaneko, Y. (2013). Secondary psychoses: an update. World Psychiatry: Official Journal of the World Psychiatric Association, 12, 4–15. https://doi.org/10.1002/wps.20001.Google Scholar
Lee, K. et al. (2019). Right hippocampus atrophy is independently associated with Alzheimer’s disease with psychosis. Psychogeriatrics: The Official Journal of the Japanese Psychogeriatric Society, 19, 105–110. https://doi.org/10.1111/psyg.12369.Google Scholar
Lenka, A., Pagonabarraga, J., Pal, P. K., Bejr-Kasem, H. and Kulisvesky, J. (2019). Minor hallucinations in Parkinson disease: a subtle symptom with major clinical implications. Neurology, 93, 259–266. https://doi.org/10.1212/WNL.0000000000007913.Google Scholar
Luna, L. P. et al. (2022). A systematic review and meta-analysis of structural and functional brain alterations in individuals with genetic and clinical high-risk for psychosis and bipolar disorder. Progress in Neuropsychopharmacology and Biological Psychiatry, 117, 110540. https://doi.org/10.1016/j.pnpbp.2022.110540.Google Scholar
Lyketsos, C. G., Lopez, O., Jones, B., Fitzpatrick, A. L., Breitner, J. and DeKosky, S. (2002). Prevalence of neuropsychiatric symptoms in dementia and mild cognitive impairment: results from the cardiovascular health study. JAMA, 288, 1475–1483. https://doi.org/10.1001/jama.288.12.1475.Google Scholar
Malhi, G. S., Gessler, D. and Outhred, T. (2017). The use of lithium for the treatment of bipolar disorder: recommendations from clinical practice guidelines. Journal of Affective Disorders, 217, 266–280.Google Scholar
McEvoy, J. P. (2019). FDA-approved medications to treat tardive dyskinesia. The Journal of Clinical Psychiatry, 81, NU18041BR3C. https://doi.org/10.4088/JCP.NU18041BR3C.Google Scholar
Mckeith, I. G. et al. (2017). Diagnosis and management of dementia with Lewy bodies: fourth consensus report of the DLB Consortium. Neurology, 89, 88–100. https://doi.org/10.1212/WNL.0000000000004058.Google Scholar
Meyers, B. S. et al. (2010). A double-blind randomized controlled trial of olanzapine plus sertraline vs olanzapine plus placebo for psychotic depression: the study of pharmacotherapy of psychotic depression (STOP-PD). Archives of General Psychiatry, 66, 838–847. https://doi.org/10.1001/archgenpsychiatry.2009.79.Google Scholar
Mühlbauer, V., Möhler, R., Dichter, M. N., Zuidema, S. U., Köpke, S. and Luijendijk, H. J. (2021). Antipsychotics for agitation and psychosis in people with Alzheimer’s disease and vascular dementia. The Cochrane Database of Systematic Reviews, 12, CD013304. https://doi.org/10.1002/14651858.CD013304.pub2.Google Scholar
Munoz-Negro, J. E. et al. (2018). A psychopathological comparison between delusional disorder and schizophrenia. The Canadian Journal of Psychiatry, 63, 12–19. https://doi.org/10.1177/0706743717706347.Google Scholar
Naasan, G. et al. (2021). Psychosis in neurodegenerative disease: differential patterns of hallucination and delusion symptoms. Brain: A Journal of Neurology, 144, 999–1012. https://doi.org/10.1093/brain/awaa413.Google Scholar
Nagendra, J. and Snowdon, J. (2020). An Australian study of delusional disorder in late life. International Psychogeriatrics, 32, 453–462. https://doi.org/10.1017/S1041610219000966.Google Scholar
Nelson, J. C. and Charney, D. S. (1981). The symptoms of major depressive illness. The American Journal of Psychiatry, 138, 1–13. https://doi.org/10.1176/ajp.138.1.1.Google ScholarPubMed
Nguyen, T. T., Eyler, L. T. and Jeste, D. V. (2018). Systemic biomarkers of accelerated aging in schizophrenia: a critical review and future directions. Schizophrenia Bulletin, 44, 398–408. https://doi.org/10.1093/schbul/sbx069.Google Scholar
Nilsson, F. M., Sørensen, T. N. and Enggard, H. (2018). Diagnosis and treatment of paranoid and schizophrenia-like psychosis in elderly patients. Ugeskrift for laeger, 180, V03180179.Google Scholar
Outeiro, T. F. et al. (2019). Dementia with Lewy bodies: an update and outlook. Molecular Neurodegeneration, 14, 5. https://doi.org/10.1186/s13024-019-0306-8.Google Scholar
Paik, S. H., Ahn, J. S., Min, S., Park, K. C. and Kim, M. H. (2018). Impact of psychotic symptoms on clinical outcomes in delirium. PloS One, 13, e0200538. https://doi.org/10.1371/journal.pone.0200538.Google Scholar
Patterson, T. L., Mausbach, B. T., McKibbin, C., Goldman, S., Bucardo, J. and Jeste, D. V. (2006). Functional adaptation skills training (FAST): a randomized trial of a psychosocial intervention for middle-aged and older patients with chronic psychotic disorders. Schizophrenia Research, 86, 291–299. https://doi.org/10.1016/j.schres.2006.05.017.CrossRefGoogle Scholar
Perälä, J. et al. (2007). Lifetime prevalence of psychotic and bipolar I disorders in a general population. Archives of General Psychiatry, 64, 19–28. https://doi.org/10.1001/archpsyc.64.1.19.Google Scholar
Perry, E. K. et al. (1990). Evidence of a monoaminergic-cholinergic imbalance related to visual hallucinations in Lewy body dementia. Journal of Neurochemistry, 55, 1454–1456. https://doi.org/10.1111/j.1471-4159.1990.tb03162.x.Google Scholar
Rajji, T. K., Ismail, Z. and Mulsant, B. H. (2009). Age at onset and cognition in schizophrenia: meta-analysis. The British Journal of Psychiatry: the Journal of Mental Science, 195, 286–293. https://doi.org/10.1192/bjp.bp.108.060723.Google Scholar
Rajji, T. K., Mamo, D. C. and Holden, J. (2022). Cognitive-behavioral social skills training for patients with late-life schizophrenia and the moderating effect of executive dysfunction. Schizophrenia Research, 239, 160–167.Google Scholar
Reeves, S. et al. (2017). Therapeutic window of dopamine D2/3 receptor occupancy to treat psychosis in AD. Brain, 140, 1117–1127. https://doi.org/10.1093/brain/aww359.Google Scholar
Rengel, K. F. et al. (2021). Motoric subtypes of delirium and long-term functional and mental health outcomes in adults after critical illness. Critical Care Medicine, 49, e521–e532. https://doi.org/10.1097/CCM.0000000000004920.Google Scholar
Reynolds, C. F., Jeste, D. V., Sachdev, P. and Blazer, D. G. (2022). Mental health care for older adults: recent advances and new directions in clinical practice and research. World Psychiatry, 21, 336–363. https://doi.org/10.1002/wps.20996.Google Scholar
Sajatovic, M. et al. (2015). A report on older-age bipolar disorder from the International Society for Bipolar Disorders Task Force. Bipolar Disorders, 17, 689–704. https://doi.org/10.1111/bdi.12331.Google Scholar
Scarmeas, N. et al. (2005). Delusions and hallucinations are associated with worse outcome in Alzheimer disease. Archives of Neurology, 62, 1601–1608. https://doi.org/10.1001/archneur.62.10.1601.Google Scholar
Schneider, L. S. et al. (2006). Effectiveness of atypical antipsychotic drugs in patients with Alzheimer’s disease. The New England Journal of Medicine, 355, 1525–1538. https://doi.org/10.1056/NEJMoa061240.Google Scholar
Schneider, L. S., Dagerman, K. S. and Insel, P. (2005). Risk of death with atypical antipsychotic drug treatment for dementia: meta-analysis of randomized placebo-controlled trials. JAMA, 294, 1934–1943. https://doi.org/10.1001/jama.294.15.1934.Google Scholar
Stafford, J., Howard, R. and Kirkbride, J. B. (2018). The incidence of very late-onset psychotic disorders: a systematic review and meta-analysis, 1960-2016. Psychological Medicine, 48, 1775–1786. https://doi.org/10.1017/S0033291717003452.Google Scholar
Stroup, T. S. et al. (2021). Age-specific prevalence and incidence of dementia diagnoses among older US adults with schizophrenia. JAMA Psychiatry, 78, 632–641. https://doi.org/10.01/jamapsychiatry.2021.0042.Google Scholar
Takamiya, A. et al. (2022). Neural substrates of psychotic depression: findings from the global ECT-MRI research collaboration. Schizophrenia Bulletin, 48, 514–523. https://doi.org/10.1093/schbul/sbab122.Google Scholar
Tampi, R. R. and Jeste, D. V. (2022). Dementia is more than memory loss: neuropsychiatric symptoms of dementia and their nonpharmacological and pharmacological management. The American Journal of Psychiatry, 179, 528–543. https://doi.org/10.1176/appi.ajp.20220508.CrossRefGoogle ScholarPubMed
Tampi, R. R., Young, J., Hoq, R., Resnick, K. and Tampi, D. J. (2019). Psychotic disorders in late life: a narrative review. Therapeutic Advances in Psychopharmacology, 9, 2045125319882798. https://doi.org/10.1177/2045125319882798.Google Scholar
Tonkonogy, J. M. and Geller, J. L. (1999). Late-onset paranoid psychosis as a distinct clinicopathologic entity: magnetic resonance imaging data in elderly patients with paranoid psychosis of late onset and schizophrenia of early onset. Neuropsychiatry, Neuropsychology, and Behavioral Neurology, 12, 230–235.Google Scholar
Uchida, H., Mamo, D. C., Mulsant, B. H., Pollock, B. G. and Kapur, S. (2009). Increased antipsychotic sensitivity in elderly patients: evidence and mechanisms. The Journal of Clinical Psychiatry, 70, 397–405. https://doi.org/10.4088/jcp.08r04171.Google Scholar
Vahia, I. V. et al. (2010). Is late-onset schizophrenia a subtype of schizophrenia? Acta psychiatrica Scandinavica, 122, 414–426. https://doi.org/10.1111/j.1600-0447.2010.01552.x.Google Scholar
Vermeulen, T., Lauwers, T., Van Diermen, L., Sabbe, B. G., van der Mast, R. C. and Giltay, E. J. (2019). Cognitive deficits in older adults with psychotic depression: a meta-analysis. The American Journal of Geriatric Psychiatry: Official Journal of the American Association for Geriatric Psychiatry, 27, 1334–1344. https://doi.org/10.1016/j.jagp.2019.07.011.Google Scholar
Voisey, J., Swagell, C. D., Hughes, I. P., Lawford, B. R., Young, R. M. and Morris, C. P. (2012). A novel DRD2 single-nucleotide polymorphism associated with schizophrenia predicts age of onset: HapMap tag-single-nucleotide polymorphism analysis. Genetic Testing and Molecular Biomarkers, 16, 77–81. https://doi.org/10.1089/gtmb.2011.0085.Google Scholar
Volkert, J., Schulz, H., Härter, M., Wlodarczyk, O. and Andreas, S. (2013). The prevalence of mental disorders in older people in Western countries - a meta-analysis. Ageing Research Reviews, 12, 339–353. https://doi.org/10.1016/j.arr.2012.09.004.Google Scholar
Wake, R. et al. (2016). Regional cerebral blood flow in late-onset schizophrenia: a SPECT study using 99mTc-ECD. European Archives of Psychiatry and Clinical Neuroscience, 266, 3–12. https://doi.org/10.1007/s00406-015-0607-z.Google Scholar
Webster, R. and Holroyd, S. (2000). Prevalence of psychotic symptoms in delirium. Psychosomatics, 41, 519–522. https://doi.org/10.1176/appi.psy.41.6.519.Google Scholar
Wu, Y. C. et al. (2019). Association of delirium response and safety of pharmacological interventions for the management and prevention of delirium: a network meta-analysis. JAMA Psychiatry, 76, 526–535. https://doi.org/10.1001/jamapsychiatry.2018.4365.Google Scholar
Young, R. C. et al. (2017). GERI-BD: a randomized double-blind controlled trial of lithium and divalproex in the treatment of mania in older patients with bipolar disorder. The American Journal of Psychiatry, 174, 1086–1093. https://doi.org/10.1176/appi.ajp.2017.15050657.Google Scholar